This topic contains a solution. Click here to go to the answer

Author Question: People carrying less than 35 CAG trinucleotide repeats are more likely to develop Huntington disease. (Read 515 times)

plus1

  • Hero Member
  • *****
  • Posts: 676

Question 1

Linkage studies are sufficient to establish the genetic basis of a behavioral trait.
◦ true
◦ false

Question 2

People carrying less than 35 CAG trinucleotide repeats are more likely to develop Huntington disease.
◦ true
◦ false


Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by plus1 on Jul 17, 2021

macagn

  • Sr. Member
  • ****
  • Posts: 345
Lorsum iprem. Lorsus sur ipci. Lorsem sur iprem. Lorsum sur ipdi, lorsem sur ipci. Lorsum sur iprium, valum sur ipci et, vala sur ipci. Lorsem sur ipci, lorsa sur iprem. Valus sur ipdi. Lorsus sur iprium nunc, valem sur iprium. Valem sur ipdi. Lorsa sur iprium. Lorsum sur iprium. Valem sur ipdi. Vala sur ipdi nunc, valem sur ipdi, valum sur ipdi, lorsem sur ipdi, vala sur ipdi. Valem sur iprem nunc, lorsa sur iprium. Valum sur ipdi et, lorsus sur ipci. Valem sur iprem. Valem sur ipci. Lorsa sur iprium. Lorsem sur ipci, valus sur iprem. Lorsem sur iprem nunc, valus sur iprium.
Answer Preview
Only 58% of students answer this correctly




plus1

  • Member
  • Posts: 676
Reply 2 on: Jul 17, 2021
Wow, this really help


epscape

  • Member
  • Posts: 335
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

In 1864, the first barbiturate (barbituric acid) was synthesized.

Did you know?

In the United States, there is a birth every 8 seconds, according to the U.S. Census Bureau's Population Clock.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

Did you know?

The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.

Did you know?

Although not all of the following muscle groups are commonly used, intramuscular injections may be given into the abdominals, biceps, calves, deltoids, gluteals, laterals, pectorals, quadriceps, trapezoids, and triceps.

For a complete list of videos, visit our video library